Cost-effectiveness of district-wide seasonal malaria chemoprevention when implemented through routine malaria control programme in Kita, Mali using fixed point distribution
Halimatou Diawara(Unknown), Lesong Conteh(London School of Economics and Political Science), Issaka Sagara(Inserm), Patrick Walker(Uniformed Services University of the Health Sciences), Fatou Diawara, Jules Mihigo(Centers for Disease Control and Prevention), Laura C. Steinhardt(Centers for Disease Control and Prevention), Laeticia Duval(Centre d'Économie de la Sorbonne), Erin Eckert(United States Agency for International Development), Elisa Sicuri(Barcelona Institute for Global Health), Matthew Cairns(University of London), Alassane Dicko(Ministère de la Santé et de l'Hygiène Publique), Beh Kamaté(Mali-Folkecenter), Aboubacar Sadou(U.S. President's Malaria Initiative)
Cited by 10
Related Papers
Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial
|The Lancet|2021|457
Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial
|The Lancet|2024|345